Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Mar 12 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-12-2025

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 12, 2025, titled "Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases